All articles tagged with #expert reviews
Originally Published 4 months ago — by CNN
Under the Trump administration, the FDA is moving to phase out the practice of consulting outside experts for drug reviews, citing efficiency, but critics argue this reduces transparency and public oversight, potentially impacting the rigor and accountability of drug approval processes.
Originally Published 4 months ago — by KFF Health News
Under the Trump administration, the FDA is moving to eliminate the practice of consulting outside experts for drug reviews, arguing it saves time and resources, but critics say it reduces transparency and public trust in drug approval decisions. The agency plans to rely more on complete response letters and internal reviews, sparking concerns about the loss of public and expert input in the regulatory process.